CN100365015C - 一种十二肽、含有该十二肽的复合物,其制备方法及在制备肝癌治疗药物中的应用 - Google Patents
一种十二肽、含有该十二肽的复合物,其制备方法及在制备肝癌治疗药物中的应用 Download PDFInfo
- Publication number
- CN100365015C CN100365015C CNB2005100002737A CN200510000273A CN100365015C CN 100365015 C CN100365015 C CN 100365015C CN B2005100002737 A CNB2005100002737 A CN B2005100002737A CN 200510000273 A CN200510000273 A CN 200510000273A CN 100365015 C CN100365015 C CN 100365015C
- Authority
- CN
- China
- Prior art keywords
- liver cancer
- dodecapeptide
- peptide
- tsst
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
稀释梯度 | 原液 | 10<sup>-1</sup> | 10<sup>-2</sup> | 10<sup>-3</sup> | 10<sup>-4</sup> | 10<sup>-5</sup> | 10<sup>-6</sup> | 10<sup>-7</sup> | 阴性对照 |
样品 | 2.946 | 0.781 | 0.668 | 0.498 | 0.436 | 0.347 | 0.264 | 0.330 | 0.132 |
细胞类型 | - | - | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
7721 | 0.097 | 0.112 | 0.860 | 1.024 | 0.917 | 0.699 | 0.670 | 0.764 | 0.825 | 0.913 |
7402 | 0.098 | 0.132 | 0.824 | 0.707 | 1.262 | 0.580 | 0.618 | 0.684 | 0.652 | 0.790 |
HL-02 | 0.011 | 0.043 | 0.112 | 0.176 | 0.091 | 0.205 | 0.137 | 0.108 | 0.155 | 0.203 |
编号/稀释倍数 | 阴性 | 原液 | 10<sup>1</sup> | 10<sup>2</sup> | 10<sup>3</sup> | 10<sup>4</sup> | 10<sup>5</sup> | 10<sup>-6</sup> |
12肽蛋白 | 0.089 | 1.397 | 0.652 | 0.829 | 0.914 | 0.938 | 0.941 | 0.952 |
抑制率(%) | 53.3 | 40.7 | 34.6 | 32.9 | 32.6 | 31.9 |
组别 | 高剂量(2.50mg/kg) | 中剂量(0.50mg/kg) | 低剂量(0.10mg/kg) | TSST-1对照组(0.47mg/kg) | N.S对照组 |
瘤重(g)肿瘤抑制率 | 0.3249±0.193469.35%<sup>***</sup> | 0.3615±0.181265.90.%<sup>***</sup> | 0.4075±0.179861.55%<sup>***</sup> | 0.4828±0.215254.45%<sup>**</sup> | 1.0600±0.3566- |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100002737A CN100365015C (zh) | 2005-01-10 | 2005-01-10 | 一种十二肽、含有该十二肽的复合物,其制备方法及在制备肝癌治疗药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100002737A CN100365015C (zh) | 2005-01-10 | 2005-01-10 | 一种十二肽、含有该十二肽的复合物,其制备方法及在制备肝癌治疗药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1803832A CN1803832A (zh) | 2006-07-19 |
CN100365015C true CN100365015C (zh) | 2008-01-30 |
Family
ID=36866002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100002737A Expired - Fee Related CN100365015C (zh) | 2005-01-10 | 2005-01-10 | 一种十二肽、含有该十二肽的复合物,其制备方法及在制备肝癌治疗药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100365015C (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030092077A1 (en) * | 2001-05-04 | 2003-05-15 | Ramarao Chodavarapu S. | Human sperm activator peptides |
US20040058457A1 (en) * | 2002-08-29 | 2004-03-25 | Xueying Huang | Functionalized nanoparticles |
-
2005
- 2005-01-10 CN CNB2005100002737A patent/CN100365015C/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030092077A1 (en) * | 2001-05-04 | 2003-05-15 | Ramarao Chodavarapu S. | Human sperm activator peptides |
US20040058457A1 (en) * | 2002-08-29 | 2004-03-25 | Xueying Huang | Functionalized nanoparticles |
Also Published As
Publication number | Publication date |
---|---|
CN1803832A (zh) | 2006-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2315252T3 (es) | Composiciones y metodos para tratar infecciones usando analogos de indolicidina. | |
AU2005270336B2 (en) | Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent | |
CN102481341B (zh) | 蛋白原及其使用方法 | |
US20240092894A1 (en) | Antibody fusion protein and related compositions for targeting cancer | |
CN1089606C (zh) | 一种修饰的超抗原和一种寻找靶物化合物的缀合物和该缀合物的用途 | |
CN109517073A (zh) | 一种靶向***的融合肽及其应用 | |
WO2007056867A1 (en) | Modified pore-forming protein toxins and use thereof | |
US20120195895A1 (en) | Fusion Protein of an Anti-CD20 Antibody Fab Fragment and Lidamycin, a Method for Preparing the Same, and the Use Thereof | |
CN109467607A (zh) | 一种靶向肿瘤的酸性敏感融合肽及其应用 | |
KR20190094382A (ko) | Ny-eso에 대한 고친화력 tcr | |
CN102757481A (zh) | 金黄色葡萄球菌肠毒素b的功能表位、与其特异性结合的单克隆抗体及其应用 | |
CN101633699B (zh) | 一种含抗体模拟物的新型抗生素及其制备方法与应用 | |
CN102516392B (zh) | 一种癌靶向超抗原融合蛋白及制备方法及用途 | |
CN101143902B (zh) | 抗HER2单链抗体-力达霉素强化融合蛋白HER2(Fv-LDM) | |
CN100365015C (zh) | 一种十二肽、含有该十二肽的复合物,其制备方法及在制备肝癌治疗药物中的应用 | |
CN101070350A (zh) | 针对cd13的靶向肽与力达霉素构成的强化融合蛋白ngr-ldp-ae | |
Kheirandish et al. | Specific targeting of a pore-forming toxin (listeriolysin O) to LHRH-positive cancer cells using LHRH targeting peptide | |
CN102127154A (zh) | A54-gflg-dox偶联物及其偶联方法和应用 | |
CN101475643B (zh) | 一种双单链抗体强化融合蛋白dFv-LDP-AE及其制备方法和应用 | |
CN106432475A (zh) | 高亲和力 ny‑eso t 细胞受体 | |
CN100519577C (zh) | 重组白喉毒素及其制备方法和应用 | |
Namvar et al. | Cloning and soluble expression of mature ${\alpha} $-luffin from Luffa cylindrica in E. coli using SUMO fusion protein | |
CN104531730A (zh) | 产气荚膜梭菌α毒素人源化单链抗体8B | |
CN110156889A (zh) | 高亲和力HBs T细胞受体 | |
CN101880327A (zh) | 蝎镇痛抗肿瘤缬精甘肽融合体及其获得方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Jiang Yongqiang Inventor after: Jiang Hua Inventor after: Zheng Yuling Inventor after: Li Hanping Inventor after: Wang Hairong Inventor after: Hao Huaijie Inventor after: Ning Baoan Inventor after: Ma Ru Inventor before: Jiang Yongqiang Inventor before: Zheng Yuling Inventor before: Li Hanping Inventor before: Wang Hairong Inventor before: Hao Huaijie Inventor before: Ning Baoan Inventor before: Ma Ru |
|
CB03 | Change of inventor or designer information | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080130 Termination date: 20200110 |
|
CF01 | Termination of patent right due to non-payment of annual fee |